Insider record · § CEO,
10% Treace John T. insider buys
Every disclosed SEC Form 4 open-market purchase by 10% Treace John T. (CEO, · TMCI), with the stock's move after each filing. Disclosures are public record; returns are informational, not investment advice.
Disclosed buys
4
Total bought
$976K
Avg Δ7d
+7.0%
Win rate · 7d
67%
Avg Δ30d
+23.1%
Last filing
2026-08-24
Buy history
| Filed | Ticker | Company | Value | Price @ | Δ1d | Δ7d | Δ30d |
|---|---|---|---|---|---|---|---|
| 2026-08-24 | TMCI | Treace Medical Concepts, Inc. | $247K | $4.37 | +10.1% | — | — |
| 2026-06-11 | TMCI | Treace Medical Concepts, Inc. | $211K | $4.23 | −4.0% | −0.9% | +8.3% |
| 2026-06-01 | TMCI | Treace Medical Concepts, Inc. | $178K | $3.46 | +0.3% | +2.0% | +22.3% |
| 2026-05-28 | TMCI | Treace Medical Concepts, Inc. | $341K | $3.08 | +12.3% | +19.8% | +38.6% |